Hysingla ER Generic Is Now Available

The generic formulation of Hysingla ER, hydrocodone bitartrate ER tablets, has been released by Alvogen. Hysingla ER is an abuse-deterrent extended-release Schedule II opioid. Hysingla ER is FDA approved for the management of pain, severe enough to require daily, around the clock, long term opioid treatment, where alternative treatment options are inadequate. Hydrocodone ER tablets are dosed once daily and available in multiple strengths (20mg, 30mg, 40mg, 60mg, 80mg, 100mg, and 120mg).

Generic prescription drugs approved by the FDA have the same high quality and strength as brand name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.